Hepion Pharmaceuticals, Inc.

General ticker "HEPA" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $3.9M (TTM average)

Hepion Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -17.7%.

Estimated limits based on current volatility of 11.1%: low 0.29$, high 0.36$

Factors to consider:

  • Current price 96.0% below estimated low
  • Earnings for 12 months up through Q4 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [31.40$, 167.51$]
  • 2024-12-30 to 2025-12-30 estimated range: [7.04$, 42.64$]

Financial Metrics affecting the HEPA estimates:

  • Negative: Non-GAAP EPS, $ of -497.42 <= 0.04
  • Negative: negative Operating income
  • Negative: Industry operating cash flow per share per price (median), % of -13.30 <= 2.82
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -20.82 <= 0
  • Negative: Operating cash flow per share per price, % of -5.74 <= 1.79
  • Negative: negative Industry operating income (median)
  • Negative: 0 < Interest expense per share, $ of 0
  • Negative: Inventory ratio change, % of 100 > 1.05
  • Positive: 22.52 < Shareholder equity ratio, % of 40.24 <= 43.26

Similar symbols

Short-term HEPA quotes

2025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-020.30.40.50.60.70.80.91
Price $

Long-term HEPA plot with estimates

02004006008001000Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025−150−100−500
HEPAS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $30.40MM $45.49MM $48.45MM
Operating Income $-30.40MM $-45.49MM $-48.45MM
Non-Operating Income $-2.32MM $0.40MM $-0.89MM
Interest Expense $0.01MM $0.01MM $0.01MM
R&D Expense $20.40MM $33.27MM $35.64MM
Income(Loss) $-32.72MM $-45.08MM $-49.34MM
Taxes $0.01MM $-2.88MM $-0.41MM
Profit(Loss)* $-32.72MM $-42.20MM $-48.93MM
Stockholders Equity $93.00MM $49.86MM $7.28MM
Assets $103.55MM $60.24MM $18.09MM
Operating Cash Flow $-31.22MM $-34.96MM $-40.89MM
Capital expenditure $0.13MM $0.02MM $0.01MM
Investing Cash Flow $-0.13MM $-0.01MM $-0.01MM
Financing Cash Flow $81.98MM $-5.14MM $4.49MM
Earnings Per Share** $-9.31 $-11.07 $-12.32

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.